Who funds Parkinson's disease research?

We count 93 funded Parkinson's disease projects, active between 2021 and 2033, from 5 funders. The most came from EU · ERC (25 projects), EU · MSCA (25 projects) and Wellcome (13 projects). The median award is $1.6M, across the 89 of 93 projects that list an amount.

Funded projects

93

Funders

5

Median award

$1.6M

Open calls now

2

Top funders of Parkinson's disease research

Projects whose title or summary mentions Parkinson's disease. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open Parkinson's disease funding calls

2 open calls mention Parkinson's disease today.

• DoW Parkinson’s, Early Investigator Research Award
  Defense Health Agency Contracting Activity - DHACANot specifiedDeadline: November 6, 2026 ·
• DoW Parkinson’s, Investigator-Initiated Research Award
  Defense Health Agency Contracting Activity - DHACANot specifiedDeadline: November 6, 2026 ·

Funded Parkinson's disease projects

A sample, latest start first, at most three per program.

• Unravelling the lipid landscape in lysosomal storage disorders and associated Parkinson's disease: insights for drug discovery
  Wellcome · £3,181,897 · ends 2033
• Understanding and Controlling Amyloid Polymorphism: From Test Tube to Tissue
  Wellcome · £2,863,103 · ends 2032
• Peripheral Modulators Of Neurodegeneration Along The Gut-brain Axis In Synucleinopathies
  Wellcome · £4,500,000 · ends 2031
• Mapping the physiological regulation and function of the Parkinson's disease-associated kinase PINK1
  UKRI · MRC · £2,614,262 · ends 2031
• Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
  NIH · NINDS · $3,136,413 · ends 2030
• eMB: Multiscale Analysis of Neural Dynamical Differences Between Parkinsonian and Healthy Animals
  NSF · MPS · $279,994 · ends 2029
• Unraveling the Mechanisms of Cognitive and Affective Symptoms in Parkinson’s Disease: Towards Personalized Therapeutic Interventions
  UKRI · UKRI FLF · £1,480,521 · ends 2029
• Small Molecule Ligands Targeting Pathological Tau Signaling In AD And Related Dementias
  NIH · NIA · $3,336,256 · ends 2029
• Collaborative Research: FDT-BioTech: Mechanistic-Neural Foundations for Digital Twins of Parkinson's Disease Symptom Dynamics Under Levodopa Treatment
  NSF · MPS · $400,000 · ends 2029
• Anxiety and depression in a nonhuman primate model of synucleinopathy
  NIH · NINDS · $3,064,072 · ends 2029

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “parkinson”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.